BFRG Insider Trading
Insider Ownership Percentage: 25.16%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $128,339.19
Bullfrog AI Share Price & Price History
Current Price: $1.15
Price Change: ▲ Price Increase of +0.06 (5.50%)
As of 12/4/2025 05:00 PM ET
Bullfrog AI Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 7/7/2025 | Vininder Singh | CEO | Sell | 29,002 | $1.50 | $43,503.00 | 2,292,446 | |
| 7/3/2025 | Vininder Singh | CEO | Sell | 6,039 | $1.61 | $9,722.79 | 2,321,448 | |
| 7/2/2025 | Vininder Singh | CEO | Sell | 7,554 | $1.57 | $11,859.78 | 2,327,487 | |
| 7/1/2025 | Vininder Singh | CEO | Sell | 7,405 | $1.53 | $11,329.65 | 2,335,041 | |
| 4/3/2025 | Vininder Singh | CEO | Sell | 27,958 | $1.44 | $40,259.52 | 2,348,341 | |
| 4/1/2025 | Vininder Singh | CEO | Sell | 7,245 | $1.61 | $11,664.45 | 2,385,201 | |
| 10/9/2024 | Vininder Singh | CEO | Sell | 5,695 | $2.59 | $14,750.05 | 2,442,446 | |
| 10/7/2024 | Vininder Singh | CEO | Sell | 5,911 | $2.57 | $15,191.27 | 2,453,101 | |
| 10/3/2024 | Vininder Singh | CEO | Sell | 5,592 | $2.66 | $14,874.72 | 2,467,013 | |
| 10/1/2024 | Vininder Singh | CEO | Sell | 14,405 | $2.65 | $38,173.25 | 2,478,041 | |
| 7/8/2024 | Vininder Singh | CEO | Sell | 10,670 | $1.47 | $15,684.90 | 2,504,197 | |
| 7/5/2024 | Vininder Singh | CEO | Sell | 7,095 | $1.58 | $11,210.10 | 2,514,867 | |
| 4/1/2024 | Vininder Singh | CEO | Sell | 43,056 | $2.99 | $128,737.44 | 2,549,390 | |
| 1/22/2024 | Vininder Singh | CEO | Sell | 25,000 | $7.50 | $187,500.00 | 2,597,294 | |
| 1/16/2024 | Vininder Singh | CEO | Sell | 8,516 | $2.55 | $21,715.80 | 2,647,294 | |
| 1/12/2024 | Vininder Singh | CEO | Sell | 1,515 | $2.56 | $3,878.40 | 2,655,810 | |
| 1/10/2024 | Vininder Singh | CEO | Sell | 4,780 | $2.75 | $13,145.00 | 2,662,985 | |
| 1/8/2024 | Vininder Singh | CEO | Sell | 5,184 | $2.88 | $14,929.92 | 2,670,909 | |
| 1/5/2024 | Vininder Singh | CEO | Sell | 2,644 | $2.90 | $7,667.60 | 2,676,093 | |
| 1/3/2024 | Vininder Singh | CEO | Sell | 5,676 | $2.18 | $12,373.68 | 2,682,306 | |
| 9/5/2023 | Vininder Singh | CEO | Sell | 50,000 | $2.95 | $147,500.00 | 2,692,446 | |
| 6/14/2023 | William Enright | Director | Buy | 5,000 | $4.05 | $20,250.00 | 5,000 | |
Bullfrog AI Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/17/2025 | Anson Funds Management LP | 80,750 | $0.11M | 0.0% | N/A | 0.788% |  |
| 8/12/2025 | J.W. Cole Advisors Inc. | 22,050 | $33K | 0.0% | -43.5% | 0.234% |  |
| 5/12/2025 | Virtu Financial LLC | 20,504 | $34K | 0.0% | N/A | 0.218% |  |
| 2/14/2025 | Two Sigma Securities LLC | 20,701 | $41K | 0.0% | N/A | 0.238% |  |
| 2/13/2025 | Raymond James Financial Inc. | 15,000 | $30K | 0.0% | N/A | 0.172% |  |
| 2/12/2025 | Geode Capital Management LLC | 47,093 | $94K | 0.0% | +31.0% | 0.541% |  |
| 2/6/2025 | Raymond James Financial Inc. | 15,000 | $30K | 0.0% | N/A | 0.172% |  |
| 11/15/2024 | XTX Topco Ltd | 10,317 | $30K | 0.0% | -44.5% | 0.118% |  |
| 8/12/2024 | XTX Topco Ltd | 18,580 | $32K | 0.0% | N/A | 0.237% |  |
| 8/9/2024 | Renaissance Technologies LLC | 19,800 | $34K | 0.0% | N/A | 0.252% |  |
| 5/2/2024 | Fortem Financial Group LLC | 53,300 | $0.17M | 0.1% | N/A | 0.679% |  |
Data available starting January 2016
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Read More on Bullfrog AI
Volume
64,299 shs
Average Volume
89,153 shs
Market Capitalization
$13.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.61
Who are the company insiders with the largest holdings of Bullfrog AI?
Who are the major institutional investors of Bullfrog AI?
Which institutional investors are buying Bullfrog AI stock?
In the last quarter, BFRG stock was bought by institutional investors including:
- Anson Funds Management LP